Medication info

TGP Simvastatin 20 mg

Prescription medicationTabletOralApproval withdrawn
Ingredient · strength
Simvastatin›20mg / 1 tablet
Manufacturer / importer
Haitai HDB Co., Ltd.
Appearance
Yellowish-brown oval film-coated tablet
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Approval withdrawn

MFDS item code 201307299 · Approved 2013.05.10

This product's status changed to Approval withdrawn on 2025.05.29. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Improvement of hyperlipidemia, improvement of familial hypercholesterolemia in children, prevention of cardiovascular disease
Who takes it
Adults · Children
Adult dose
Patients must follow a standard cholesterol-lowering diet before and during treatment with this medicine. 1. Reduction of the risk of cardiovascular disease The recommended initial dose is 40 mg of simvastatin once daily. 2. Hyperlipidemia 1) Reduction of risk in patients with hypercholesterolemia and coronary heart disease, and hyperlipidemia The usual recommended initial dose is 20 mg of this medicine once daily in the evening. Patients with mild to moderate hypercholesterolemia may start with 10 mg of this medicine. Administration of 5 ~ 40 mg of this medicine once daily in the evening is recommended. Adjust the dose as appropriate according to the initial LDL cholesterol level before treatment, the treatment goal, and the patient's response to the medicine. Measure cholesterol levels 4 weeks after starting treatment and periodically thereafter to adjust the dose. Reduce the dose if the cholesterol level falls below the target level. Because of the increased risk of myopathy, including rhabdomyolysis, use of the 80 mg dose of this medicine, particularly during the first year of treatment, is restricted to patients who have taken 80 mg of this medicine for 12 months or longer without evidence of muscle toxicity (see 1. Warnings under Precautions for Use). 2) Refer below for recommended doses in patients receiving concomitant fibrates (excluding gemfibrozil and fenofibrate), amiodarone, verapamil, diltiazem, or amlodipine, and in specific patient groups (i.e., patients with homozygous familial hypercholesterolemia, elderly patients, and patients with renal impairment) (see 6. Interactions under Precautions for Use). (1) Administration to patients with homozygous familial hypercholesterolemia Controlled clinical trial results indicate that patients with homozygous familial hypercholesterolemia should receive 40 mg of this medicine once daily in the evening. Administer this medicine in combination with other lipid-lowering treatments (e.g., LDL apheresis), or when other lipid-lowering treatments are not available. (2) In elderly patients, a daily dose of 20 mg of this medicine may achieve the maximum reduction in cholesterol levels. (3) Administration to patients receiving verapamil, diltiazem, or dronedarone When this medicine is coadministered to patients receiving verapamil, diltiazem, or dronedarone, the dose of this medicine should not exceed 10 mg per day. (4) Administration to patients receiving amiodarone, amlodipine, or ranolazine When this medicine is coadministered to patients receiving amiodarone, amlodipine, or ranolazine, the dose of this medicine should not exceed 20 mg per day. (5) Coadministration with other lipid-lowering agents This medicine is effective when administered alone or in combination with a bile acid sequestrant. When this medicine is coadministered with a fibrate (excluding gemfibrozil (see 2. Do not administer to the following patients under Precautions for Use) and fenofibrate), the dose of this medicine should not exceed 10 mg per day. (6) Administration to patients with renal impairment Because this medicine is not excreted extensively by the kidneys, dose adjustment is not required in patients with mild to moderate renal impairment. However, in patients with severe renal impairment, start with an initial dose of 5 mg once daily and monitor carefully.
Child dose
10 ~ 17 years: The recommended initial dose is 10 mg of this medicine once daily in the evening. The recommended dose range is 10 ~ 40 mg per day, and the recommended maximum dose is 40 mg per day. Adjust the dose as appropriate for each patient according to the recommended treatment goal. Allow an interval of 4 weeks or longer between dose adjustments.

Ingredients

Manufacturer
Haitai HDB Co., Ltd.

Efficacy & effects

Improvement of hyperlipidemia, improvement of familial hypercholesterolemia in children, prevention of cardiovascular disease

  • Coronary heart disease
  • diabetes
  • peripheral vascular disease
  • stroke
  • other cerebrovascular diseases
  • hyperlipidemia
  • primary hypercholesterolemia
  • mixed dyslipidemia
  • abnormal beta-lipoproteinemia
  • hypertriglyceridemia
  • heterozygous familial hypercholesterolemia
View approved original text

This medicine helps reduce the risk of cardiovascular disease in adult patients with a history of coronary heart disease, diabetes, peripheral vascular disease, or stroke. It lowers the risk of death from coronary heart disease, as well as the risk of non-fatal myocardial infarction and stroke, and also reduces the risk of complications related to vascular surgery. Additionally, it effectively lowers high cholesterol and triglyceride levels in patients with primary hypercholesterolemia and mixed dyslipidemia and increases good cholesterol (HDL). It is also used in pediatric patients with familial hypercholesterolemia and is utilized as an adjunct to improve blood lipid levels in conjunction with dietary therapy. Thus, this drug is used to improve various risk factors associated with cardiovascular diseases and enhance cardiovascular health.

How to take

Adult dose

Patients must follow a standard cholesterol-lowering diet before and during treatment with this medicine. 1. Reduction of the risk of cardiovascular disease The recommended initial dose is 40 mg of simvastatin once daily. 2. Hyperlipidemia 1) Reduction of risk in patients with hypercholesterolemia and coronary heart disease, and hyperlipidemia The usual recommended initial dose is 20 mg of this medicine once daily in the evening. Patients with mild to moderate hypercholesterolemia may start with 10 mg of this medicine. Administration of 5 ~ 40 mg of this medicine once daily in the evening is recommended. Adjust the dose as appropriate according to the initial LDL cholesterol level before treatment, the treatment goal, and the patient's response to the medicine. Measure cholesterol levels 4 weeks after starting treatment and periodically thereafter to adjust the dose. Reduce the dose if the cholesterol level falls below the target level. Because of the increased risk of myopathy, including rhabdomyolysis, use of the 80 mg dose of this medicine, particularly during the first year of treatment, is restricted to patients who have taken 80 mg of this medicine for 12 months or longer without evidence of muscle toxicity (see 1. Warnings under Precautions for Use). 2) Refer below for recommended doses in patients receiving concomitant fibrates (excluding gemfibrozil and fenofibrate), amiodarone, verapamil, diltiazem, or amlodipine, and in specific patient groups (i.e., patients with homozygous familial hypercholesterolemia, elderly patients, and patients with renal impairment) (see 6. Interactions under Precautions for Use). (1) Administration to patients with homozygous familial hypercholesterolemia Controlled clinical trial results indicate that patients with homozygous familial hypercholesterolemia should receive 40 mg of this medicine once daily in the evening. Administer this medicine in combination with other lipid-lowering treatments (e.g., LDL apheresis), or when other lipid-lowering treatments are not available. (2) In elderly patients, a daily dose of 20 mg of this medicine may achieve the maximum reduction in cholesterol levels. (3) Administration to patients receiving verapamil, diltiazem, or dronedarone When this medicine is coadministered to patients receiving verapamil, diltiazem, or dronedarone, the dose of this medicine should not exceed 10 mg per day. (4) Administration to patients receiving amiodarone, amlodipine, or ranolazine When this medicine is coadministered to patients receiving amiodarone, amlodipine, or ranolazine, the dose of this medicine should not exceed 20 mg per day. (5) Coadministration with other lipid-lowering agents This medicine is effective when administered alone or in combination with a bile acid sequestrant. When this medicine is coadministered with a fibrate (excluding gemfibrozil (see 2. Do not administer to the following patients under Precautions for Use) and fenofibrate), the dose of this medicine should not exceed 10 mg per day. (6) Administration to patients with renal impairment Because this medicine is not excreted extensively by the kidneys, dose adjustment is not required in patients with mild to moderate renal impairment. However, in patients with severe renal impairment, start with an initial dose of 5 mg once daily and monitor carefully.

Child dose

10 ~ 17 years: The recommended initial dose is 10 mg of this medicine once daily in the evening. The recommended dose range is 10 ~ 40 mg per day, and the recommended maximum dose is 40 mg per day. Adjust the dose as appropriate for each patient according to the recommended treatment goal. Allow an interval of 4 weeks or longer between dose adjustments.

Precautions

This medication requires caution as it may cause muscle problems. Especially at high doses, there is an increased risk of muscle damage known as myopathy or rhabdomyolysis. Patients who are allergic to this medication or have impaired liver function, as well as pregnant or nursing women, should not use it. Additionally, it can be dangerous when taken with certain strong medications, so consultation with a physician is necessary. Individuals who consume excessive amounts of alcohol or have liver or kidney problems, those with hypothyroidism or a history of muscle disorders, elderly individuals, and women should be particularly cautious when using this medication. If symptoms such as muscle pain, muscle weakness, or pain occur while taking this medication, it is essential to notify a physician immediately, and sometimes it may be necessary to discontinue the medication. Regular liver function tests are important as liver function abnormalities may occur. If symptoms of hepatitis or jaundice appear, notify a physician immediately. This medication may interact with other drugs, so if you are taking other medications, be sure to inform healthcare providers, particularly when used with certain antibiotics, antifungals, immunosuppressants, calcium channel blockers, etc., dosage adjustment or discontinuation may be necessary. Women who are planning to become pregnant or are potentially pregnant should use contraception and must discontinue the medication immediately if pregnancy is confirmed. Use in children aged 10 years and older, especially between the ages of 10 and 17, should be limited, and consultation with healthcare providers regarding effects on growth and maturation is necessary. Elderly patients may respond differently to the medication, so caution is required during use. In case of overdose, seek immediate medical attention for appropriate treatment. This medication must be stored out of reach of children, and it should be kept in its original container to maintain its quality.

Side effects

  • Myopathy
  • rhabdomyolysis
  • abdominal pain
  • weakness
  • constipation
  • diarrhea
  • dyspepsia
  • bloating
  • nausea
  • headache
Show 92 more
  • upper respiratory infection
  • edema
  • atrial fibrillation
  • gastritis
  • diabetes
  • myalgia
  • insomnia
  • dizziness
  • bronchitis
  • sinusitis
  • eczema
  • urinary tract infection
  • muscle cramp
  • arthralgia
  • taste disturbance
  • ocular motility disorder
  • facial paresis
  • tremor
  • sensory disturbance
  • peripheral neuropathy
  • peripheral nerve paralysis
  • mental disorder
  • anxiety
  • sleep disorder
  • nightmares
  • depression
  • cognitive impairment
  • severe myasthenia gravis
  • ocular myasthenia gravis
  • hepatitis
  • liver dysfunction
  • jaundice
  • pancreatitis
  • liver failure
  • cholecystic obstructive jaundice
  • hepatic steatosis
  • liver cirrhosis
  • fulminant hepatic necrosis
  • liver cancer
  • anorexia
  • vomiting
  • alopecia
  • pruritus
  • skin changes
  • lichenoid drug eruption
  • gynecomastia
  • decreased libido
  • sexual dysfunction
  • cataract progression
  • ocular muscle paralysis
  • anemia
  • elevated aminotransferases
  • elevated ALP
  • elevated γ-GTP
  • increased bilirubin levels
  • thyroid dysfunction
  • elevated serum creatine kinase
  • abnormal liver function tests
  • increased HbA1c
  • elevated fasting blood glucose
  • sensory numbness in limbs
  • paresthesia
  • cold sensation
  • thrombocytopenia
  • anaphylaxis
  • angioedema
  • lupus erythematosus-like syndrome
  • polymyalgia rheumatica
  • dermatomyositis
  • vasculitis
  • purpura
  • thrombocytopenia
  • leukopenia
  • hemolytic anemia
  • positive antinuclear antibody
  • increased erythrocyte sedimentation rate
  • eosinophilia
  • arthritis
  • arthralgia
  • urticaria
  • photosensitivity
  • fever
  • chills
  • flushing
  • fatigue
  • dyspnea
  • toxic epidermal necrolysis
  • mucous membrane syndrome
  • erythema multiforme
  • interstitial lung disease
  • vomiting
  • mucus stool

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to prevent the ingress of air or moisture. It is advisable to maintain a storage temperature between 1 degree and 30 degrees Celsius. Proper storage will help keep the medication effective for a longer period.

Appearance and packaging

Appearance

Yellowish-brown oval film-coated tablet

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.